Radioiodine treatment of distant metastases

Thyroid Cancer (Second Edition): A Comprehensive Guide to Clinical Management

Volumn , Issue , 2006, Pages 411-425

  Van Nostrand, Douglas ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892313780     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-995-0_47     Document Type: Chapter

References (49)

1. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid. JAMA 1946; 132:838-847.
2. Leeper RD. The effect of I-131 therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin Endocrinol Metab 1973; 36:1143-1152.
3. Nemec J, Zamrazil V, Pohunkova D, Rohling S. Radioiodide treatment of pulmonary metastases of differentiated thyroid cancer: results and prognostic factors. Nucl Med 1979; 18:86-90.
4. Maheshwari YK, Strattton Hill C, Haynie TP, et al. Iodine-131 therapy in differentiated thyroid carcinoma: M.D. Anderson Hospital experience. Cancer 1981; 47:664-671.
5. Brown AP, Greening W P, McCready VR, et al. Radioiodine treatment of Metastatic thyroid carcinoma: the Royal Marsden hospital experience: Br J Radiol 1984; 57:323-327.
6. Massin JP, Savoie JC, Garnier H, et al. Pulmonary metastases in differentiated thyroid carcinoma: study of 58 cases with implications for the primary tumor treatment. Cancer 1984; 53:982-992.
7. Samaan, NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985; 65:376-380.
8. Schlumberger M, Arcangioli O, Piekarski JD, et al. Detection of and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988; 29:1790-1794.
9. Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988; 67:501-508.
10. Hoie J, Stenwig AE, Kullman G, Lindegaard M. D istant metastases in papillary thyroid cancer: a review of 91 patients. Cancer 1988; 61:1-6.
11. Marcocci C, Pacini F, Elisi R, et al. Clinical and biological behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989; 106:960-966.
12. Woods WJ, Singletary SE, Hickey RC. Current results of treatment for distant metastatic well-differentiated thyroid carcinoma. Arch Surg 1989; 124:1374-1377.
13. Proye CAG, Dromer DHR, Carnaille BM, et al. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine? World J Surg 1992; 16:640-646.
14. Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993; 34:1626-1631.
15. Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine. World J Surg 1994; 18:600-604.
16. Dinneen SF, Valimaki MJ, Bergstralh, EJ, et al. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995; 80:2041-2045.
17. Vassilopoulou-Sellin R, Libshitz HI, Haynie TP. Papillary thyroid cancer with pulmonary metastases beginning in childhood. Clinical course over three decades. Med Pediatr Oncol 1995; 24:119-122.
18. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598-605.
19. Menzel C, Grunwald F, Schomburg A, et al. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma. J Nucl Med 1996; 37:1496-1503.
20. Vassilopoulou-Sellin R, Schultz P, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996; 78:494-501.
21. Sisson JC, Giordano TJ, Jamadar DA, et al. Treatment of micronodular pulmonary metastases from papillary thyroid cancer with I-131. Cancer 1996; 78:2184-2192.
22. Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated thyroid carcinoma of the thyroid. Am J Surg 1996; 172:692-694.
23. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998; 30:1531-1536.
24. Fanchiang JK, Lin JD, Huang MJ, Shih NW. Papillary and follicu-lar thyroid carcinomas with bone metastases: A series of 39 cases during a period of 18 years. Chang Gung Med J 1998; 21:377-382.
25. Pittas AG, Adler M, Fazzari M, et al. Bone metastases from thyroid carcinoma; clinical characteristics and prognostic variables in one hundred forty six patients. Thyroid 2000; 10:261-268.
26. Petrich T, Widjaja A, Musholt TJ, et al. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side effects and influence of age. E ur J Nucl Med 2001; 28:203-208.
27. Bernier MO, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001; 86:1568-1473.
28. Hindié E, Melliere D, Lange F, et al. Functioning pulmonary metas-tases of thyroid cancer: does radioiodine influence the prognosis? E ur J Nucl Med 2003; 30:974-981.
29. Ronga G, Filesi M, Montesano T, et al. Lung metastases from differentiated thyroid carcinoma. A 40 years' experience. Q J Nucl Med Mol Imaging 2004; 48:12-19.
30. Sisson JC, Jamadar DDA, Kazerooni EA, et al. Treatment of micro-nodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine? Thyroid 1998; 8: 215-221.
31. Robbins RJ, Larson SM, Pentlow KS, Tuttle RM. Treatment of thyroid cancer metastases with I-131 following thyroid hormone withdrawal or recombinant human TSH. Thyroid 2003; 13:702.
32. Dorn R, Kopp J, Vogt H, et al. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach. J Nucl Med 2003; 44:451-456.
33. Zettinig G, Fueger B, Passier C, et al. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma-surgery or conventional therapy? Clin Endocrinol 2002; 56:377-382.
34. Chiu AC, Delpassand ES, Sherman SI. Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 1997; 82:3637-3642.
35. McWilliams RR, Giannini C, Hay ID, et al. Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer 2003; 98:356-362.
36. Beierwaltes WH. The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 1978; 8:79-94.
37. Thomas SR, Maxon HR, Kereiakes JG. In vivo quantitation of lesion radioactivity using external counting methods. Med Phys 1976; 3: 253-255.
38. Thomas SR, Maxon HR, Kereiakes JG, Saenger EL. Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer. Radiology 1977; 122:731-737.
39. Maxon HR, Thomas SR, Hertzbert VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983; 309:937-941.
40. Benua RS, Cicale NR, Sonenberg M, Rawson RW. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med 1962; 87:171-182.
41. Leeper RD. Thyroid cancer. Med Clin North Am 1985; 69:1079-1096.
42. Schlumberger J, Tubiana M, De Vathaire F, et al. Long term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 63: 960-967.
43. Samuel AM, Rajashekharrao B. Radioiodine therapy for well-differentiated thyroid cancer: A quantitative dosimetric evaluation for remnant thyroid ablation after surgery. J Nucl Med 1994; 35: 1944-1950.
44. Kassis AI, Adelstein SJ. Radiobiologic principles of radionuclide therapy. J Nucl Med 2005; 46:4S-12S.
45. Atkins FB, Van Nostrand D, Kulkarni K, et al. The frequency with which empiric amounts of radioiodine "over-" or "under-" treat patients with metastatic well-differentiated thyroid cancer. J Nucl Med 2005; 46:129P.
46. Leeper R. Controversies in the treatment of thyroid cancer: the New York Memorial Hospital Approach. Thyroid Today 1982; 5:1-4.
47. Sisson JC, Shulkin BL, Lawson S. Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of I-131. J Nucl Med 2003; 44:898-903.
48. Reynolds JC. Comparison of I-131 absorbed radiation doses in children and adults; a tool for estimating therapeutic I-131 doses in children. In Robbins J, editor. Treatment of thyroid cancer in children. Springfield, VA: US Department of Commerce Technology Administration, National Technical Information Service, 1994:127-135.
49. Maxon HR. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med 1999; 43:313-323.